MK-5172

Biorbyt

MK-5172

16

1206524-85-7

Research Use Only

C29H38N4O7

554.6346

MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.

O1C(N([H])[C@]([H])(C(N2C([H])([H])C([H])(C([H])([H])C2([H])C(=O)O[H])OC2C(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]3([H])C([H])([H])C13[H])=NC1C([H])=C([H])C(=C([H])C=1N=2)OC([H])([H])[H])=O)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])=O

12352200